000300597 001__ 300597
000300597 005__ 20250423112814.0
000300597 0247_ $$2doi$$a10.1002/jcsm.13812
000300597 0247_ $$2pmid$$apmid:40254293
000300597 0247_ $$2ISSN$$a2190-5991
000300597 0247_ $$2ISSN$$a2190-6009
000300597 037__ $$aDKFZ-2025-00811
000300597 041__ $$aEnglish
000300597 082__ $$a610
000300597 1001_ $$00000-0001-9734-4632$$aGerhalter, Teresa$$b0
000300597 245__ $$aLongitudinal Follow-Up of Patients With Duchenne Muscular Dystrophy Using Quantitative 23Na and 1H MRI.
000300597 260__ $$aHoboken, NJ$$bWiley$$c2025
000300597 3367_ $$2DRIVER$$aarticle
000300597 3367_ $$2DataCite$$aOutput Types/Journal article
000300597 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1745329327_26883
000300597 3367_ $$2BibTeX$$aARTICLE
000300597 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000300597 3367_ $$00$$2EndNote$$aJournal Article
000300597 500__ $$a#LA:E020#
000300597 520__ $$aQuantitative muscle MRI commonly evaluates disease activity and muscle wasting in Duchenne muscular dystrophy (DMD). Disturbances in ion homeostasis contribute to DMD pathophysiology, but their relationships with disease progression is unclear. 23Na MRI may provide insights into the disease course and treatment response. This longitudinal study assessed whether sodium levels are elevated in DMD patients regardless of fat fraction (FF) and whether baseline sodium levels influence FF changes over time. Additionally, we quantified the effect of slice selection on measured sodium values.Thirteen DMD boys (age 7.8 ± 2.4 years) underwent MRI of lower leg muscles at 3T at three visits, spaced 6 months apart. We assessed FF for disease progression and water T2, pH, apparent tissue sodium concentration (aTSC), and intracellular-weighted 23Na signal (ICwS) for disease activity. Fourteen healthy boys (age 9.5 ± 1.7 years) underwent the same MRI protocol once. Linear regression and mixed-effect modelling were used to examine sodium level increases and their impact on FF changes.In DMD, muscles with FF < 10% exhibited significantly elevated aTSC (24.8 ± 4.6 mM vs. 14.5 ± 2.1 mM in controls, p < 0.001) and higher ICwS (23.6 ± 2.5 a.u. vs. 14.1 ± 2.1 a.u., p < 0.001). At Visit 1, FF values showed a significant negative association with aTSC (β = -17.30, p = 0.016) and ICwS (β = -21.02, p < 0.001). The first mixed-effect model, which assessed aTSC alone, showed no significant effect on FF progression but indicated a weak trend (p = 0.098). The second, more comprehensive model-incorporating also ICwS and water T2-revealed that FF changes were positively associated with aTSC (p = 0.0023) and negatively associated with ICwS and wT2 (p < 0.001 and p = 0.025, respectively), with ICwS showing a significant interaction with time (p = 0.0033). Varying slice positioning and slice number demonstrated minimal impact on aTSC and ICwS, with low CV (2%-4%) in the mid-belly region.The study demonstrates significant MRI-based changes related to dystrophic alterations in DMD. We identified early alterations in sodium homeostasis, independent of FF. Our findings suggest that the relationship between sodium levels and FF progression is complex and may not be fully explained by total sodium measurements alone. Given the small sample size, further validation in larger cohorts is needed. Combined 1H and 23Na-MRI may offer deeper insights into how metabolic and ionic changes interact with FF progression and overall disease activity.
000300597 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000300597 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000300597 650_7 $$2Other$$aDuchenne muscular dystrophy
000300597 650_7 $$2Other$$afat fraction
000300597 650_7 $$2Other$$amuscle imaging
000300597 650_7 $$2Other$$aquantitative MRI
000300597 650_7 $$2Other$$askeletal muscle
000300597 650_7 $$2Other$$asodium
000300597 650_7 $$09NEZ333N27$$2NLM Chemicals$$aSodium
000300597 650_2 $$2MeSH$$aHumans
000300597 650_2 $$2MeSH$$aMuscular Dystrophy, Duchenne: diagnostic imaging
000300597 650_2 $$2MeSH$$aMale
000300597 650_2 $$2MeSH$$aChild
000300597 650_2 $$2MeSH$$aMagnetic Resonance Imaging: methods
000300597 650_2 $$2MeSH$$aLongitudinal Studies
000300597 650_2 $$2MeSH$$aFollow-Up Studies
000300597 650_2 $$2MeSH$$aMuscle, Skeletal: diagnostic imaging
000300597 650_2 $$2MeSH$$aDisease Progression
000300597 650_2 $$2MeSH$$aAdolescent
000300597 650_2 $$2MeSH$$aSodium: metabolism
000300597 7001_ $$aMarty, Benjamin$$b1
000300597 7001_ $$aGast, Lena V$$b2
000300597 7001_ $$aRoemer, Frank$$b3
000300597 7001_ $$aBaudin, Pierre-Yves$$b4
000300597 7001_ $$aTrollmann, Regina$$b5
000300597 7001_ $$aUder, Michael$$b6
000300597 7001_ $$aCarlier, Pierre G$$b7
000300597 7001_ $$0P:(DE-He78)054fd7a5195b75b11fbdc5c360276011$$aNagel, Armin$$b8$$eLast author$$udkfz
000300597 773__ $$0PERI:(DE-600)2586864-0$$a10.1002/jcsm.13812$$gVol. 16, no. 2, p. e13812$$n2$$pe13812$$tJournal of cachexia, sarcopenia and muscle$$v16$$x2190-5991$$y2025
000300597 909CO $$ooai:inrepo02.dkfz.de:300597$$pVDB
000300597 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)054fd7a5195b75b11fbdc5c360276011$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000300597 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000300597 9141_ $$y2025
000300597 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2024-12-19$$wger
000300597 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-19
000300597 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-19
000300597 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-08-08T17:05:34Z
000300597 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-08-08T17:05:34Z
000300597 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-08-08T17:05:34Z
000300597 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2024-08-08T17:05:34Z
000300597 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-19
000300597 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-19
000300597 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-19
000300597 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-19
000300597 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-19
000300597 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-19
000300597 9202_ $$0I:(DE-He78)E020-20160331$$kE020$$lE020 Med. Physik in der Radiologie$$x0
000300597 9201_ $$0I:(DE-He78)E020-20160331$$kE020$$lE020 Med. Physik in der Radiologie$$x0
000300597 980__ $$ajournal
000300597 980__ $$aVDB
000300597 980__ $$aI:(DE-He78)E020-20160331
000300597 980__ $$aUNRESTRICTED